HIV-1 Viral Protein-R (VPR) Protects against Lethal Superantigen Challenge While Maintaining Homeostatic T Cell Levels in Vivo
Open Access
- 30 November 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (5) , 910-921
- https://doi.org/10.1016/j.ymthe.2005.05.009
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Recombination and the Population Structures of Bacterial PathogensAnnual Review of Microbiology, 2001
- Toxic Shock Syndrome and Bacterial Superantigens: An UpdateAnnual Review of Microbiology, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- PATHOGENESIS AND MANAGEMENT OF MULTIPLE ORGAN DYSFUNCTION OR FAILURE IN SEVERE SEPSIS AND SEPTIC SHOCKCritical Care Clinics, 2000
- SEVERE SEPSIS AND SEPTIC SHOCKCritical Care Clinics, 2000
- GRAM-POSITIVE SEPSISInfectious Disease Clinics of North America, 1999
- Treating Patients with Severe SepsisNew England Journal of Medicine, 1999
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- Induction of cell differentiation by human immunodeficiency virus 1 vprCell, 1993
- Molecular biology of the human immunodeficiency virus type 1The FASEB Journal, 1991